Home  »  News   »  AMAM’s 2023 Market Dance: Up 351.54% – Tim...

AMAM’s 2023 Market Dance: Up 351.54% – Time to Invest?

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded an increase of 351.54%. However, over the last six months, the performance has been weaker by 14.78%. The price of AMAM decreased -22.82% over the last 30 days. And in the last five days, it has fallen by -11.94%.

Ambrx Biopharma Inc. (AMAM) current stock price is $10.25. During the last trading session, the stock soared, reaching $10.63 after opening at $8.77. The stock’s lowest point was $8.65 before it closed at $9.30.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Ambrx Biopharma Inc.’s stock has had a calm market performance. The 1-year high for the company’s stock was $16.86 on 07/05/23, and the lowest price during the same period was recorded at $0.38 on 12/08/22.

52-week price history of AMAM Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Ambrx Biopharma Inc.’s current trading price is -39.21% away from its 52-week high, while its distance from the 52-week low is 2597.37%. The stock’s price range over this timeframe has been between $0.38 and $16.86. The shares of the Healthcare sector company recorded a trading volume of approximately 1.0 million for the day, which was comparatively higher than the average daily volume of 0.35 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Ambrx Biopharma Inc. (AMAM) has experienced a quarterly decline of -31.71% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 679.37M and boasts a workforce of 66 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 13.82, with a change in price of +0.52. Similarly, Ambrx Biopharma Inc. recorded 412,882 in trading volume during the last 100 days, posting a change of +5.34%.

AMAM’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for AMAM stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

AMAM Stock Stochastic Average

The raw stochastic average for Ambrx Biopharma Inc. over the last 50 days is presently at 24.57%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 27.97%. Further, the company’s Stochastic %K and %D values for the last 20 days were 15.14% and 8.46%, respectively.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts